Business
BioLife Sciences (OTCPK: BLFE) to Receive $4.5M USD Strategic Investment From BeMotion Inc. to Expand and Accelerate Commercialization of Non-Contact Smart Vending Technology
BioLife Sciences (OTCPK: BLFE) to Receive $4.5M USD Strategic Investment From BeMotion Inc. to Expand and Accelerate Commercialization of Non-Contact Smart Vending Technology.
About this update from Biolife Sciences Inc.
[{"type":"text","content":"\n Toronto, Ontario, Canada, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) is pleased to announce it has reached an agreement with BeMotion Inc. for strategic investment to accelerate the commercialization of its advanced smart digital vending platform.  BeMotion will invest a total of $4.5M USD as a combination of services and capital equipment into BioLife Sciences to fulfill and expand their current contracts. This investment represents a significant step towards BioLife and BeMotion realizing a shared vision of smart digital vending which provides a solution to last-mile product distribution in the rapidly shifting landscape of retail which is re-shaping where and how consumers purchase products. “We are excited to deepen our relationship with BeMotion on their next-generation vending platforms.  It is clear to us that BeMotion has the most advanced vending technology in the world in addition to the IT expertise necessary to exploit the M-Commerce and Digital marketing capabilities. The platform is very dynamic which will allow us to expand this solution into new markets across North America.” – said Mr. DeFour, CEO of BioLife Sciences. The DCN Vending and Marketplace platform allows users to interact with the machines without contact through their smartphone and boasts a staggering array of features that benefit retailers such as M-Commerce, Products Directory, Loyalty Program, Delivery, Digital Advertising and Detailed Analytics. “We believe that smart vending is the future of retail. BioLife’s unique position within food & beverage markets combined with their strategic distribution relationships within the Canadian market made our choice to partner with BioLife very easy.” – said Mr. Abu Hassan, CEO of BeMotion Inc. BioLife Sciences plans to roll-out the systems throughout their existing distribution network with the initial targets being transit hubs across Canada. About BioLife Sciences Inc. BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption.  Its core business develops, licenses and distributes antimicrobial products, non-contact human temperature screening technology, and touchless vending/marketplaces. One of Bi...